adsorbed (Tdap) given intramuscularly as a single dose (0.5 ml) on day 0

3 trials

Sponsors

BioNet-Asia Co.,Ltd., BioNet-Asia Co., Ltd. 19 Soi Udomsuk 37, Sukhumvit 103 Rd., Prakanong, Bangkok 10260, Thailand, Chulalongkorn University

Conditions

Pertussis PertussisPertussis vaccine Pertussis vaccine

Phase 2

Immunogenicity and safety of various recombinant acellular pertussis-containing vaccines in healthy women of child bearing age

Active, not recruitingTCTR20180321004

BioNet-Asia Co.,Ltd.Pertussis Pertussis

Start: 2018-07-05Target: 250Updated: 2026-08-03

Immunogenicity and safety of various recombinant acellular pertussis-containing vaccines in healthy pregnant women

Active, not recruitingTCTR20180725004

BioNet-Asia Co., Ltd. 19 Soi Udomsuk 37, Sukhumvit 103 Rd., Prakanong, Bangkok 10260, ThailandPertussis Pertussis

Start: 2019-02-01Target: 400Updated: 2026-08-03

Phase 3

Safety and Antibody Responses in Adults and Elderly after Immunization with a Recombinant Pertussis Booster Dose

Active, not recruitingTCTR20190927006

Chulalongkorn UniversityPertussis vaccine Pertussis vaccine

Start: 2020-02-10Target: 750Updated: 2026-08-03

Related Papers

A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women

Vaccine2023-06-1512 citations

A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age.

2021-11-147 citations